Search Results - "McKone, E. F."
-
1
Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
Published in Scientific reports (09-08-2017)“…Deletion of phenylalanine 508 of the cystic fibrosis transmembrane conductance regulator (ΔF508 CFTR) is a major cause of cystic fibrosis (CF), one of the most…”
Get full text
Journal Article -
2
Changes in fecal microbiota with CFTR modulator therapy: A pilot study
Published in Journal of cystic fibrosis (01-09-2021)“…•People with CF often have exocrine pancreatic insufficiency (PI) and altered fecal microbiomes.•Whether the PI and resulting nutrient malabsorption causes the…”
Get full text
Journal Article -
3
Reproducibility of maximal exercise ergometer testing in patients with cystic fibrosis
Published in Chest (01-08-1999)“…Exercise testing in patients with cystic fibrosis (CF) has become an important tool in assessing disease severity and predicting overall outcome. The…”
Get more information
Journal Article -
4
The role of supplemental oxygen during submaximal exercise in patients with cystic fibrosis
Published in The European respiratory journal (01-07-2002)“…Repeated bouts of submaximal exercise are an important part of most pulmonary rehabilitation programmes. Patients with moderate-to-severe cystic fibrosis (CF)…”
Get full text
Journal Article -
5
Ivacaftor as salvage therapy in a patient with cystic fibrosis genotype F508del/R117H/IVS8-5T
Published in Journal of cystic fibrosis (01-07-2015)“…Abstract Ivacaftor is a novel CFTR potentiator that increases CFTR activity and improves clinical outcomes in cystic fibrosis (CF) patients with at least one…”
Get full text
Journal Article -
6
Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate cystic fibrosis
Published in Journal of cystic fibrosis (01-03-2008)“…Abstract Background Centralized spirometry may significantly improve quality of spirometry and reduce variability of this outcome measure in clinical trials in…”
Get full text
Journal Article -
7
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
Published in The New England journal of medicine (07-11-2019)“…Triple treatment with elexacaftor, tezacaftor, and ivacaftor in patients with cystic fibrosis who had one Phe508del allele and a minimal-function mutation…”
Get full text
Journal Article -
8
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
Published in The New England journal of medicine (16-07-2015)“…This study identified a new combination therapy for patients with cystic fibrosis homozygous for the Phe508del CFTR mutation. Treatment with ivacaftor, a CFTR…”
Get full text
Journal Article -
9
VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
Published in The New England journal of medicine (25-10-2018)“…This companion article to the VX-445 report shows that VX-659, a new CFTR potentiator, when administered with tezacaftor and ivacaftor improved lung function,…”
Get full text
Journal Article -
10
-
11
-
12
-
13
-
14
Validation and use of a parametric model for projecting cystic fibrosis survivorship beyond observed data: a birth cohort analysis
Published in Thorax (01-08-2011)“…The current lifetable approach to survival estimation is favoured by CF registries. Recognising the limitation of this approach, we examined the utility of a…”
Get more information
Journal Article -
15
-
16
Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study
Published in The Lancet (British edition) (17-05-2003)“…Over 1000 mutations of the cystic fibrosis transmembrane conductance regulator gene (CFTR) that cause cystic fibrosis have been identified. We examined the…”
Get full text
Journal Article -
17
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe
Published in ERJ open research (01-10-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in people with cystic fibrosis (pwCF) can lead to severe outcomes. In this observational…”
Get full text
Journal Article -
18
Role of arterial hypoxemia and pulmonary mechanics in exercise limitation in adults with cystic fibrosis
Published in Journal of applied physiology (1985) (01-09-2005)“…Department of Respiratory Medicine and National Referral Center for Adult Cystic Fibrosis, St. Vincent's University Hospital, Dublin, Ireland Submitted 4 May…”
Get full text
Journal Article -
19
Publications and extramural activities of general internal medicine and medicine subspecialty clinician-educators: a multicenter study
Published in Academic medicine (01-03-2005)“…Generalist clinician-educators may have more difficulty than specialists satisfying common promotion criteria (peer-reviewed publication and extramural…”
Get full text
Journal Article -
20
Use of the gas exchange threshold to noninvasively determine the lactate threshold in patients with cystic fibrosis
Published in Chest (01-06-2002)“…The anaerobic threshold (AT) is a submaximal index related to endurance exercise performance, which is usually determined by the measurement of blood lactate…”
Get more information
Journal Article